Folfirinox
(2S)-2-[[4-[(2-amino-5-formyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid;[(1S,2S)-2-azanidylcyclohexyl]azanide;[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate;5-fluoro-1H-pyrimidine-2,4-dione;oxalate;platinum(4+)
Molecular Identity
Folfirinox
(2S)-2-[[4-[(2-amino-5-formyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid;[(1S,2S)-2-azanidylcyclohexyl]azanide;[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate;5-fluoro-1H-pyrimidine-2,4-dione;oxalate;platinum(4+)
PubChem CID: 136171075
2D Structure
Properties
C65H76FN15O19Pt
Molecular Formula
1585.50
Molecular Weight
g/mol
1584.5074
Exact Mass
Da
469
TPSA
May have limited oral absorption
12
H-Bond Donors
27
H-Bond Acceptors
2500
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(8)
FolfirinoxFolfirinox RegimenFolfirinox ProtocolFluorouracil / irinotecan / leucovorin / oxaliplatinFluorouracil with irinotecan, leucovorin and oxaliplatinS900005690Fluorouracil regimen with irinotecan, leucovorin and oxaliplatinFluorouracil with irinotecan, leucovorin calcium and oxaliplatin
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Folfirinox
Loading drug network...